Brief: Akari Therapeutics Says On May 1, Torsten Hombeck, CFO, Delivered Notice Of Resignation
05/05/2023 18:13
May 5 (Reuters) - Akari Therapeutics PLC AKTX.O :
* AKARI THERAPEUTICS PLC - ON MAY 1, TORSTEN HOMBECK, CHIEF FINANCIAL
OFFICER,
DELIVERED HIS NOTICE OF RESIGNATION
Further company coverage: AKTX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Akari Therapeutics
See all newsBrief: Akari Therapeutics - Aktx-101 Demonstrates Robust Anti-Tumor Activity In Urothelial Cancer Preclinical Models
UK's Akari Therapeutics Q2 net loss widens on higher R&D for AKTX-101
Akari Therapeutics PLC reports results for the quarter ended June 30 - Earnings Summary
Akari Therapeutics PLC expected to post a loss of $1.40 a share - Earnings Preview
Brief: Akari Therapeutics Enters Strategic Research Collaboration With Whitehawk Therapeutics